Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.

@article{Gislason2007PersistentUO,
  title={Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.},
  author={Gunnar Hilmar Gislason and Jeppe N\orgaard Rasmussen and Steen Z. Abildstrom and Tina Ken Schramm and Morten Hansen and Pernille Buch and Rikke S\orensen and Fredrik Folke and Niels Gadsb\oll and S\oren Rasmussen and Lars Valeur K\ober and Mette Madsen and C Torp-Pedersen},
  journal={Circulation},
  year={2007},
  volume={116 7},
  pages={737-44}
}
BACKGROUND Undertreatment with recommended pharmacotherapy is a common problem in heart failure and may influence prognosis. We studied initiation and persistence of evidence-based pharmacotherapy in 107,092 patients discharged after first hospitalization for heart failure in Denmark from 1995 to 2004. METHODS AND RESULTS Prescriptions of dispensed… CONTINUE READING